Bill > HR1806

This bill aims to address the challenges surrounding triple-negative breast cancer (TNBC), a particularly aggressive form of breast cancer that disproportionately affects African-American and Hispanic women. The legislation directs the National Institutes of Health (NIH) to expand and intensify research on TNBC through multiple institutes and offices, with a focus on understanding its prevalence, incidence, and potential prevention methods. The bill authorizes funding for research from 2026 to 2031 and requires the Centers for Disease Control and Prevention to develop a public education program about TNBC, including information on its risk factors, particularly for minority women. Additionally, the bill mandates the Health Resources and Services Administration to disseminate information to healthcare providers about TNBC, ensuring they are informed about current research, treatment options, and the elevated risk for minority women. The legislation recognizes that TNBC is unique because its cancer cells lack estrogen and progesterone receptors and do not have excess HER2 protein, making traditional hormone therapies ineffective and early detection crucial. By addressing research, education, and information dissemination, the bill seeks to improve understanding, detection, and treatment of this challenging form of breast cancer.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/1806/all-info